Nuveen Asset Management, LLC Enanta Pharmaceuticals Inc Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 55,607 shares of ENTA stock, worth $558,850. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,607

Previous 89,387 37.79%

Holding current value

$558,850

Previous $1.56 Million 53.78%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$11.43 - $17.02 $386,105 - $574,935	-33,780 Reduced 37.79%	55,607 $721,000
Q1 2024 May 13, 2024	BUY	$10.08 - $17.46 $340,502 - $589,798	33,780 Added 60.75%	89,387 $1.56 Million
Q4 2023 Feb 14, 2024	BUY	$8.18 - $10.78 $867 - $1,142	106 Added 0.19%	55,607 $523,000
Q3 2023 Nov 14, 2023	SELL	$11.09 - $22.13 $6,598 - $13,167	-595 Reduced 1.06%	55,501 $619,000
Q1 2023 May 15, 2023	SELL	$38.82 - $54.59 $205,124 - $288,453	-5,284 Reduced 8.61%	56,096 $2.27 Million
Q4 2022 Feb 14, 2023	SELL	$40.77 - $53.73 $370,803 - $488,674	-9,095 Reduced 12.91%	61,380 $2.86 Million
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $74,511 - $109,969	-1,543 Reduced 2.14%	70,475 $3.66 Million
Q2 2022 Aug 15, 2022	SELL	$38.13 - $76.93 $2.8 Million - $5.65 Million	-73,462 Reduced 50.5%	72,018 $3.4 Million
Q1 2022 May 16, 2022	BUY	$56.06 - $74.11 $2.76 Million - $3.66 Million	49,322 Added 51.29%	145,480 $9.67 Million
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $879,496 - $1.42 Million	14,612 Added 17.92%	96,158 $6.4 Million
Q3 2021 Nov 12, 2021	BUY	$41.02 - $58.65 $15,997 - $22,873	390 Added 0.48%	81,546 $4.76 Million
Q2 2021 Aug 16, 2021	SELL	$43.76 - $53.11 $169,044 - $205,163	-3,863 Reduced 4.54%	81,156 $3.57 Million
Q1 2021 May 17, 2021	SELL	$41.69 - $54.95 $102,307 - $134,847	-2,454 Reduced 2.81%	85,019 $4.19 Million
Q4 2020 Feb 16, 2021	SELL	$41.16 - $47.47 $128,172 - $147,821	-3,114 Reduced 3.44%	87,473 $3.68 Million
Q3 2020 Nov 16, 2020	SELL	$43.36 - $53.53 $933,410 - $1.15 Million	-21,527 Reduced 19.2%	90,587 $4.15 Million
Q2 2020 Aug 14, 2020	BUY	$46.37 - $57.58 $615,886 - $764,777	13,282 Added 13.44%	112,114 $5.63 Million
Q1 2020 May 14, 2020	SELL	$40.22 - $62.0 $756,900 - $1.17 Million	-18,819 Reduced 16.0%	98,832 $5.08 Million
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $5.34 Million - $6.14 Million	-92,118 Reduced 43.91%	117,651 $7.27 Million
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $722,041 - $1.06 Million	12,018 Added 6.08%	209,769 $12.6 Million
Q2 2019 Aug 15, 2019	BUY	$81.3 - $97.35 $16.1 Million - $19.3 Million	197,751 New	197,751 $16.7 Million

Others Institutions Holding ENTA

# of Institutions

Shares Held

21.2M

Call Options Held

10.4K

Put Options Held

2.3K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $208M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Enanta Pharmaceuticals Inc Transaction History